Cargando…

High Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study

Introduction: Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. Methods: This study aims at evaluating the prevalence of S. stercoralis at the hospi...

Descripción completa

Detalles Bibliográficos
Autores principales: Requena-Méndez, Ana, Salas-Coronas, Joaquin, Salvador, Fernando, Gomez-Junyent, Joan, Villar-Garcia, Judith, Santin, Miguel, Muñoz, Carme, González-Cordón, Ana, Cabezas Fernández, Maria Teresa, Sulleiro, Elena, Arenas, Maria del Mar, Somoza, Dolors, Vazquez-Villegas, Jose, Treviño, Begoña, Rodríguez, Esperanza, Valls, Maria Eugenia, Llaberia-Marcual, Jaume, Subirá, Carme, Muñoz, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167856/
https://www.ncbi.nlm.nih.gov/pubmed/32053864
http://dx.doi.org/10.3390/pathogens9020107
Descripción
Sumario:Introduction: Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. Methods: This study aims at evaluating the prevalence of S. stercoralis at the hospital level in migrant populations or long term travellers being attended in out-patient and in-patient units as part of a systematic screening implemented in six Spanish hospitals. A cross-sectional study was conducted and systematic screening for S. stercoralis infection using serological tests was offered to all eligible participants. Results: The overall seroprevalence of S. stercoralis was 9.04% (95%CI 7.76–10.31). The seroprevalence of people with a risk of infection acquired in Africa and Latin America was 9.35% (95%CI 7.01–11.69), 9.22% (7.5–10.93), respectively. The number of individuals coming from Asian countries was significantly smaller and the overall prevalence in these countries was 2.9% (95%CI −0.3–6.2). The seroprevalence in units attending potentially immunosuppressed patients was significantly lower (5.64%) compared with other units of the hospital (10.20%) or Tropical diseases units (13.33%) (p < 0.001). Conclusions: We report a hospital-based strongyloidiasis seroprevalence of almost 10% in a mobile population coming from endemic areas suggesting the need of implementing strongyloidiasis screening in hospitalized patients coming from endemic areas, particularly if they are at risk of immunosuppression.